2.41
price up icon2.12%   0.05
 
loading

Celularity Inc Azioni (CELU) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
95.05%
18.13
9.296 12.11 14.68 12.11
Cost Of Revenue
89.11%
7.343
3.883 2.123 1.64 -11.52
Gross Profit
99.32%
10.79
5.413 9.988 13.04 2.503
Operating Expenses
18.47%
20.07
16.94 20.16 20.42 -10.81
Benefits Costs and Expenses
23.75%
31.43
25.39 18.60 36.69 2.555
Costs And Expenses
23.75%
31.43
25.39 18.60 36.69 2.555
Operating Income/Loss
19.49%
-9.28
-11.53 -10.18 -7.376 13.31
Nonoperating Income/Loss
12.21%
-4.013
-4.571 3.687 -14.64 -3.758
Income/Loss From Continuing Operations Before Tax
17.42%
-13.29
-16.10 -6.488 -22.01 9.557
Income/Loss From Continuing Operations After Tax
19.49%
-9.28
-11.53 -10.18 -7.376 13.31
Net Income/Loss
17.42%
-13.29
-16.10 -6.488 -22.01 9.547
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.39%
0.134
21.98 21.85 21.44 -155.72
Diluted Average Shares
99.39%
0.134
21.98 21.85 21.44 -155.72
Basic Earnings Per Share
19.18%
-0.59
-0.73 -0.30 -1.03 -9.83
Diluted Earnings Per Share
19.18%
-0.59
-0.73 -0.30 -1.03 -9.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):